Viral factors in influenza pandemic risk assessment

Author:

Lipsitch Marc123ORCID,Barclay Wendy4,Raman Rahul5,Russell Charles J6,Belser Jessica A7,Cobey Sarah8,Kasson Peter M910,Lloyd-Smith James O1112ORCID,Maurer-Stroh Sebastian131415,Riley Steven1617,Beauchemin Catherine AA18ORCID,Bedford Trevor19,Friedrich Thomas C20,Handel Andreas21ORCID,Herfst Sander22,Murcia Pablo R23ORCID,Roche Benjamin24,Wilke Claus O2526ORCID,Russell Colin A27ORCID

Affiliation:

1. Center for Communicable Disease Dynamics, Harvard T. H Chan School of Public Health, Boston, United States

2. Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, United States

3. Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, United States

4. Division of Infectious Disease, Faculty of Medicine, Imperial College, London, United Kingdom

5. Department of Biological Engineering, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, United States

6. Department of Infectious Diseases, St. Jude Children’s Research Hospital, Memphis, United States

7. Centers for Disease Control and Prevention, Atlanta, United States

8. Department of Ecology and Evolutionary Biology, University of Chicago, Chicago, United States

9. Department of Biomedical Engineering, University of Virginia, Charlottesville, United States

10. Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, United States

11. Department of Ecology and Evolutionary Biology, University of California, Los Angeles, Los Angeles, United States

12. Fogarty International Center, National Institutes of Health, Bethesda, United States

13. Bioinformatics Institute, Agency for Science Technology and Research, Singapore, Singapore

14. National Public Health Laboratory, Communicable Diseases Division, Ministry of Health, Singapore, Singapore

15. School of Biological Sciences, Nanyang Technological University, Singapore, Singapore

16. MRC Centre for Outbreak Analysis and Modelling, School of Public Health, Imperial College London, London, United Kingdom

17. Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, United Kingdom

18. Department of Physics, Ryerson University, Toronto, Canada

19. Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, United States

20. Department of Pathobiological Sciences, University of Wisconsin School of Veterinary Medicine, Madison, United States

21. Department of Epidemiology and Biostatistics, College of Public Health, University of Georgia, Athens, United States

22. Department of Viroscience, Erasmus Medical Center, Rotterdam, Netherlands

23. MRC-University of Glasgow Centre For Virus Research, Glasgow, United Kingdom

24. IRD/UPMC UMMISCO, Montpellier, France

25. Center for Computational Biology and Bioinformatics, Institute for Cellular and Molecular Biology, The University of Texas at Austin, Austin, United States

26. Department of Integrative Biology, The University of Texas at Austin, Austin, United States

27. Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom

Abstract

The threat of an influenza A virus pandemic stems from continual virus spillovers from reservoir species, a tiny fraction of which spark sustained transmission in humans. To date, no pandemic emergence of a new influenza strain has been preceded by detection of a closely related precursor in an animal or human. Nonetheless, influenza surveillance efforts are expanding, prompting a need for tools to assess the pandemic risk posed by a detected virus. The goal would be to use genetic sequence and/or biological assays of viral traits to identify those non-human influenza viruses with the greatest risk of evolving into pandemic threats, and/or to understand drivers of such evolution, to prioritize pandemic prevention or response measures. We describe such efforts, identify progress and ongoing challenges, and discuss three specific traits of influenza viruses (hemagglutinin receptor binding specificity, hemagglutinin pH of activation, and polymerase complex efficiency) that contribute to pandemic risk.

Funder

National Institutes of Health

National Institute of Allergy and Infectious Diseases

National Health and Medical Research Council

Agency for Science, Technology and Research

Wellcome

Medical Research Council

National Institute of General Medical Sciences

Natural Sciences and Engineering Research Council of Canada

Ministry of Research and Innovation of Ontario

Nederlandse Organisatie voor Wetenschappelijk Onderzoek

Royal Society

Publisher

eLife Sciences Publications, Ltd

Subject

General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Cited by 80 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3